Latest News

No Results Found

Try adjusting your search to find what you’re looking for.


Broken String Biosciences Closes $15M Series A Funding Round

Broken String Biosciences (“Broken String”), a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, today announced that it has closed a $15 million Series A investment round, co-led by Illumina Ventures and Mérieux Equity Partners...

Read More

Lightcast Discovery secures $49 million in Series B financing to commercialize its single-cell platform for functional analysis

Lightcast Discovery Ltd. (“Lightcast” or the “Company”), a life science tools company developing a novel single-cell functional analysis platform, today announced the completion of a £38M (c. $49 million) Series B funding round, led by M Ventures.

Read More

Attovia Therapeutics Launches With $60 Million Series A Financing To Unlock Potential Of Novel Biparatopic Nanobody Platform

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of diseases, and Frazier Life Sciences, announced the launch of Attovia Therapeutics, a newly formed company focused on creating a pipeline of biotherapeutics in immune-mediated disease and cancer.

Read More

Pluton Biosciences Raises $16.5M Series A led by Illumina Ventures and RA Capital

Led by Illumina Ventures and RA Capital to discover and deploy microbes that will fight climate change. Illumina Ventures’ Charles Lin, PhD, who has joined Pluton’s Board of Directors, expressed his excitement about the fund’s first AgBio investment, “In the past two decades, we have witnessed how genomics revolutionized the landscape of human diagnostics and therapeutics. We expect genomics to...

Read More